Esophageal cancer developed in a radiated field: can we reduce the risk of a poor prognosis cancer?
作者信息
Schena Marina, Battaglia Angelo F, Munoz Fernando
机构信息
1st Medical Oncology Division, U. Parini Hospital, Aosta, Italy.
Radiation Oncology, U. Parini Hospital, Aosta, Italy.
出版信息
J Thorac Dis. 2017 Jul;9(7):1767-1771. doi: 10.21037/jtd.2017.06.45.
Abstract
摘要
相似文献
1
Esophageal cancer developed in a radiated field: can we reduce the risk of a poor prognosis cancer?放射野内发生的食管癌：我们能否降低预后不良癌症的风险？
J Thorac Dis. 2017 Jul;9(7):1767-1771. doi: 10.21037/jtd.2017.06.45.
2
Guidelines for prognosis in head and neck cancer with nodal metastasis.头颈部癌伴淋巴结转移的预后指南。
Laryngoscope. 1978 Jan;88(1 Pt 1):135-40. doi: 10.1002/lary.1978.88.1.135.
3
Radiation-Induced Esophageal Cancer: Investigating the Pathogenesis, Management, and Prognosis.放射性食管癌症：发病机制、治疗和预后的研究。
Medicina (Kaunas). 2022 Jul 18;58(7):949. doi: 10.3390/medicina58070949.
4
Outcomes of tracheoesophageal puncture in twice-radiated patients.两次放疗后行气管食管造瘘术的效果。
Am J Otolaryngol. 2019 Nov-Dec;40(6):102272. doi: 10.1016/j.amjoto.2019.08.003. Epub 2019 Aug 2.
5
Cyclo-oxygenase-2 expression in photon-radiated and non-radiated uveal melanomas.光辐射和非光辐射葡萄膜黑色素瘤中环氧化酶-2 的表达。
Acta Ophthalmol. 2010 Aug;88(5):582-7. doi: 10.1111/j.1755-3768.2008.01475.x. Epub 2009 Apr 23.
6
[Histopathological study of resected esophageal cancers between with and without preoperative radiation therapy].[术前放疗与未放疗食管癌切除标本的组织病理学研究]
Rinsho Byori. 1991 Apr;39(4):421-4.
7
Outcomes of Radiation-Associated Esophageal Squamous Cell Carcinoma: The MSKCC Experience.放射性食管鳞癌的预后：MSKCC 经验。
J Gastrointest Surg. 2019 Jan;23(1):11-22. doi: 10.1007/s11605-018-3958-8. Epub 2018 Sep 13.
8
Analysis on plausible factors related to the prognosis of stage IV esophageal cancer.IV期食管癌预后相关潜在因素分析
Medicine (Baltimore). 2020 Mar;99(12):e18529. doi: 10.1097/MD.0000000000018529.
9
The elevated preoperative fasting blood glucose predicts a poor prognosis in patients with esophageal squamous cell carcinoma: The Fujian prospective investigation of cancer (FIESTA) study.术前空腹血糖升高预示食管鳞状细胞癌患者预后不良：福建癌症前瞻性研究（FIESTA）
Oncotarget. 2016 Oct 4;7(40):65247-65256. doi: 10.18632/oncotarget.11247.
10
V-Raf murine sarcoma viral oncogene homolog B1 (BRAF) as a prognostic biomarker of poor outcomes in esophageal cancer patients.V-Raf 鼠肉瘤病毒癌基因同源物 B1（BRAF）作为食管癌患者预后不良的生物标志物。
BMC Gastroenterol. 2021 Feb 23;21(1):86. doi: 10.1186/s12876-021-01671-2.
引用本文的文献
1
Routine image-enhanced endoscopic surveillance for metachronous esophageal squamous cell neoplasms in head and neck cancer patients.对头颈部癌症患者的食管鳞癌异时性病变进行常规增强内镜监测。
Esophagus. 2024 Apr;21(2):131-140. doi: 10.1007/s10388-023-01039-3. Epub 2024 Jan 9.
2
Radiation-Induced Esophageal Cancer: Investigating the Pathogenesis, Management, and Prognosis.放射性食管癌症：发病机制、治疗和预后的研究。
Medicina (Kaunas). 2022 Jul 18;58(7):949. doi: 10.3390/medicina58070949.
3
Fixed-jaw technique to improve IMRT plan quality for the treatment of cervical and upper thoracic esophageal cancer.固定架技术改善颈段和胸上段食管癌调强放疗计划质量
J Appl Clin Med Phys. 2019 Oct;20(10):24-32. doi: 10.1002/acm2.12704. Epub 2019 Aug 28.
4
Integrating radiosensitive genes improves prediction of radiosensitivity or radioresistance in patients with oesophageal cancer.整合放射敏感基因可改善食管癌患者放射敏感性或放射抗性的预测。
Oncol Lett. 2019 Jun;17(6):5377-5388. doi: 10.3892/ol.2019.10240. Epub 2019 Apr 10.
5
Outcomes of Radiation-Associated Esophageal Squamous Cell Carcinoma: The MSKCC Experience.放射性食管鳞癌的预后：MSKCC 经验。
J Gastrointest Surg. 2019 Jan;23(1):11-22. doi: 10.1007/s11605-018-3958-8. Epub 2018 Sep 13.
本文引用的文献
1
Effect of Extending the Original Eligibility Criteria for the CROSS Neoadjuvant Chemoradiotherapy on Toxicity and Survival in Esophageal Cancer.扩大CROSS新辅助放化疗原入选标准对食管癌毒性和生存的影响
Ann Surg Oncol. 2017 Jul;24(7):1811-1820. doi: 10.1245/s10434-017-5797-3. Epub 2017 Feb 10.
2
Concurrent neoadjuvant chemoradiotherapy could improve survival outcomes for patients with esophageal cancer: a meta-analysis based on random clinical trials.同步新辅助放化疗可改善食管癌患者的生存结局：一项基于随机临床试验的荟萃分析
Oncotarget. 2017 Mar 21;8(12):20410-20417. doi: 10.18632/oncotarget.14669.
3
Neoadjuvant chemoradiotherapy or chemotherapy? A comprehensive systematic review and meta-analysis of the options for neoadjuvant therapy for treating oesophageal cancer.新辅助放化疗还是化疗？食管癌新辅助治疗方案的全面系统评价与荟萃分析。
Eur J Cardiothorac Surg. 2017 Mar 1;51(3):421-431. doi: 10.1093/ejcts/ezw315.
4
Oesophageal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.食管癌：ESMO 诊断、治疗及随访临床实践指南
Ann Oncol. 2016 Sep;27(suppl 5):v50-v57. doi: 10.1093/annonc/mdw329.
5
Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial.新辅助放化疗联合手术与单纯手术治疗食管或食管胃交界癌（CROSS）：一项随机对照临床试验的长期结果。
Lancet Oncol. 2015 Sep;16(9):1090-1098. doi: 10.1016/S1470-2045(15)00040-6. Epub 2015 Aug 5.
6
The impact of neoadjuvant chemoradiotherapy on perioperative outcomes, tumor pathology, and survival in clinical stage II and III esophageal cancer.新辅助放化疗对 II 期和 III 期食管癌围手术期结局、肿瘤病理学和生存的影响。
Ann Surg Oncol. 2013 Nov;20(12):3935-41. doi: 10.1245/s10434-013-3137-9. Epub 2013 Jul 27.
7
Oesophageal carcinoma.食管癌。
Lancet. 2013 Feb 2;381(9864):400-12. doi: 10.1016/S0140-6736(12)60643-6.
8
Second malignant neoplasms following radiotherapy.放疗后继发第二恶性肿瘤。
Int J Environ Res Public Health. 2012 Dec 18;9(12):4744-59. doi: 10.3390/ijerph9124744.
9
Risk of treatment-related esophageal cancer among breast cancer survivors.乳腺癌幸存者治疗相关食管癌的风险。
Ann Oncol. 2012 Dec;23(12):3081-3091. doi: 10.1093/annonc/mds144. Epub 2012 Jun 27.
10
Preoperative chemoradiotherapy for esophageal or junctional cancer.术前放化疗治疗食管或食管胃交界癌。
N Engl J Med. 2012 May 31;366(22):2074-84. doi: 10.1056/NEJMoa1112088.
Zotero 插件